Levamisole

at nematode nicotinic receptors causing spastic paralysis; host immunomodulatory effects are a separate, historically used pharmacology.

AntimicrobialImmuneReceptor agonismImmune modulation

Primary Mechanism of Action

Clinical / Scientific

Levamisole stimulates nematode muscle nAChRs, producing spastic paralysis. In mammals it has been used as an immunomodulatory adjunct in selected historical oncology protocols; agranulocytosis risk is a major labelled safety issue and is not a mechanistic “benefit”.

Pathway Targets

Nematode nAChR

Scientific explanation

Depolarizing neuromuscular agonism.

Host immune signalling

Scientific explanation

Historical immunomodulatory use; not a general recommendation.

Pathway Convergence

Clinical / Scientific

Target → pathway → downstream effect → biological consequence. This is a mechanistic map, not a treatment claim.

Nematode paralysis

Target to downstream effect: nAChR agonism → Spastic paralysis → Expulsion of susceptible worms

nAChR agonism
↓
Spastic paralysis
↓
Expulsion of susceptible worms

Mechanistically Relevant Repurposed & Adjunctive Applications

Veterinary / selected anthelmintic use

Established

Mechanistic rationale

Nicotinic anthelmintic mechanism is established. Human availability and indications are jurisdiction-specific.

Immunomodulatory adjunct

Investigational

Mechanistic rationale

Past adjunctive oncology protocols do not make this an established general immune therapy.

Mechanistic Application Matrix

Biological TargetMechanismPotential RelevanceEvidence Level
nAChRAgonismNematode muscleEstablished mechanism

Mechanistic Interaction Considerations

Agranulocytosis and vasculitis-like reactions are serious labelled risks. This page does not provide a treatment plan.

In Plain Language

Levamisole overstimulates worm muscle receptors. It also affects human immune cells in ways that have been used experimentally — and it can seriously affect white blood cells.

Compounds Sharing Pathways

Other library compounds whose structured pathway data overlap this ingredient. Shared pathways are not combination recommendations.

Nematode nAChR

Mechanistic information is provided for scientific and educational purposes. Discussion of biological pathways or investigational applications does not establish clinical efficacy or constitute individualized medical advice.